3 hours ago
1
jetcityimage/iStock Editorial via Getty Images
- UBS downgraded Thermo Fisher Scientific (NYSE:TMO) to neutral from buy due to a series of headwinds that could negatively impact life sciences R&D spend.
- The bank cut its price target to $460 from $500 (~8% upside based on July 10 close).
English (US) ·